FCT Begins Deployment of New Long-Acting HIV Prevention Injection

The Federal Capital Territory Administration (FCTA) has commenced the introduction of a new injectable medication designed to help prevent HIV infection, as part of ongoing efforts to reduce new cases in the territory.

Health authorities announced that the rollout involves Lenacapavir, a long-acting preventive drug administered twice yearly, which is being integrated into existing HIV prevention services.

Officials said the initiative is aimed at expanding available options for people at risk of HIV, especially those who find it difficult to adhere to daily preventive medication.

The programme is being implemented through the FCT health control agencies in collaboration with national HIV response bodies, with a formal flag-off held in Abuja.

According to health experts, the new injectable option represents a major shift in prevention strategy, offering a more convenient alternative to traditional daily tablets.

They added that the introduction will help strengthen Nigeria’s overall response to HIV by improving access, adherence, and uptake of preventive care services.

Authorities also noted that selected health facilities in the FCT will begin administering the drug as part of the initial phase before wider expansion.